The University of Liverpool is leading a £3 million European consortium to develop the use of particle beam therapy for treating cancer.
The `Optimisation of Medical Accelerators’ (OMA) is a research and training consortium involving 24 institutions from across Europe.
It will train 15 early stage researchers to carry out research into the treatment facility design, numerical simulations for the development of advanced therapies and novel imaging techniques.
Although significant progress has been made in the use of particle beams for cancer treatment, extensive research is still needed to maximise healthcare benefits.
Professor Carsten P. Welsch from the University’s Department of Physics, based at the Cockcroft Institute, will coordinate the consortium.
He said: “The field of particle therapy has steadily developed over the last six decades, first in physics laboratories, and starting in the late 90’s in dedicated clinical installations.
“By March 2013 about 110,000 people had received treatment with particle beams, the vast majority having been treated with protons and around 15,000 patients with heavier ions such as helium, carbon, neon, and argon.”
“OMA will push the limits in treatment facility design, imaging techniques and treatment optimisation through advanced numerical studies.
“A network of European universities, research centres, clinical facilities and industry partners with outstanding expertise in this area will jointly develop advanced schemes to assure the best possible cancer care for patients.”
The University of Liverpool has a proven track record in the coordination of large scale European networks through the successful completion of the DITANET, oPAC and LA3NET projects. OMA will directly build up on the experiences gained within these earlier initiatives and train the next generation of medical accelerator experts.
Professor Welsch added: “I am absolutely delighted that this collaboration has been funded. In close collaboration with our project partners we will provide a broad and interdisciplinary training programme to our Fellows to develop them into outstanding researchers.
“We will also organise many events for the wider research community to stimulate knowledge exchange and generate a lasting impact.”
The project is currently recruiting for its Fellowship positions that will be based at institutions across Europe. Researchers from around the world are invited to submit their application by 28 February 2016. Further information on the vacancies available through the project can be found at: http://www.oma-project.eu/
To find out more about OMA, visit: http://www.oma-project.eu.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 675265.
You must be logged in to post a comment.
All recent news
Liverpool leads new national encephalitis study
Liverpool Guild of Students designated as Hate Crime Reporting Centre
Free festival explores climate change, ‘fake news’ and more
Staying safe in the city
An open letter from UUK and UCEA to staff impacted by the latest UCU pensions and pay disputes
Researchers @LivUni have been awarded £2.6 million to lead a national study looking at new treatment for autoimmune #encephalitis
Read more here👉http://bit.ly/32fe9z3
Front page of our News site this morning 📰
Researchers are leading a study looking at new treatment for autoimmune #encephalitis, an award-winning line-up for our #LivOpenHouse festival, and how oceans are moderators of #ClimateChange.
Find it all here👉https://news.liverpool.ac.uk
Front page of our📰News site this morning
Research identifies barriers to developing seawater electrolysis tech, Virtual Engineering Centre's £4m support for SMEs and Liverpool engineers presenting research to #UKParliament
Find it all here 👉https://news.liverpool.ac.uk